6 Results for "

DOCK1

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "DOCK1" in MCE Product Catalog:

  • Targets Recommended:
1
1 Cited Publications
Cat. No.: HY-124711
CAS No.: 1996629-79-8
Purity:  99.96%
Target:  

DOCK

Research Areas:  

Cancer

TBOPP is a selective inhibitor of DOCK1 with an IC50 of 8.4 μM. TBOPP binds to the DOCK1 DHR-2 domain with high affinity (Kd of 7.1 μM), has anti-tumor activity for broader types of tumors [1].
Cat. No.: HY-136177
CAS No.: 95906-11-9
Purity:  99.81%
Tris(2,4-di-tert-butylphenyl)phosphate is an active compound from the leaves of Vitex negundo L. shows anti-inflammatory activity with evidence of inhibition for secretory Phospholipase A2 (sPLA2) through molecular docking .
Cat. No.: HY-RS03921
Research Areas:  

Others

DOCK1 Human Pre-designed siRNA Set A contains three designed siRNAs for DOCK1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Cat. No.: HY-RS20911
Research Areas:  

Others

Dock1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Dock1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Cat. No.: HY-RS27428
Research Areas:  

Others

Dock1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Dock1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

Cat. No.: HY-136177R
CAS No.: 95906-11-9
Tris(2,4-di-tert-butylphenyl)phosphate (Standard) is the analytical standard of Tris(2,4-di-tert-butylphenyl)phosphate. This product is intended for research and analytical applications. Tris(2,4-di-tert-butylphenyl)phosphate is an active compound from the leaves of Vitex negundo L. shows anti-inflammatory activity with evidence of inhibition for secretory Phospholipase A2 (sPLA2) through molecular docking .